期刊文献+

多西紫杉醇联合氟尿嘧啶及顺铂治疗晚期胃癌 被引量:8

Docetaxel in Combination with 5-Fluorouracil and Cisplatin for Advanced Gastric Cancer
下载PDF
导出
摘要 目的观察国产多西紫杉醇(TAT)联合亚叶酸钙/5-氟尿嘧啶(CF/5-Fu)及顺铂(DDP)治疗晚期胃癌的临床疗效与不良反应。方法41例晚期胃癌患者接受TAT与CF/5-Fu及DDP联合化疗:TAT75mg/m2,静滴1h,d1;CF100mg,静滴2h,d1~5;5-Fu500mg/m2,22h微泵持续静滴,d1~5;DDP25mg/m2,静滴,d1~3。28天为一个周期。治疗2个周期后评价疗效和不良反应。结果41例患者均可评价疗效。完全缓解2例,部分缓解23例,有效率61.0%。中位疾病进展时间7.5个月,中位生存期10.6个月,1年生存率41.5%。主要不良反应为骨髓抑制,脱发和周围神经炎。结论国产多西紫杉醇联合亚叶酸钙/5-氟尿嘧啶及顺铂治疗晚期胃癌缓解率高,毒副反应可以耐受。 Objective To evaluate the efficacy and toxicity of domestic Docetaxel in combination with Calcium Folinate/5-Fluorouracil and Cisplatin on advanced gastric cancer. Methods Forty-one patients with advanced gastric cancer were treated by Docetaxel 75 mg/m^2 on dr, Calcium Folinate 100mg on d1-5, 5-Fluorouracil 500mg/m^2 on d1-5, Cisplatin 25mg/m^2 on d1-3, with 28 days one cycle. The efficacy and adverse effect were evaluated after two cycles. Results Forty-one patients can be included for response rate. 2 showed complete response and 23 partial responses with an overall response rate of 61.0% (25/41). Median time to progression was 7. 5 months, and 1-year survival rates was 41.5%0 with median survival time of 10. 6 months. The main adverse effect was myelosuppression, alopecia and peripheral neuritis. Conclusion The regimen of domestic Docetaxel combined with Calcium Folinate/5-Fluorouracil and Cisplatin for patients with advanced gastric cancer produced high response rate and its toxicity is well tolerable.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第7期526-527,共2页 Cancer Research on Prevention and Treatment
关键词 多西紫杉醇 5-氟尿嘧啶 顺铂 胃癌 Docetaxel 5-Fluorouracil Cisplatin Gastric cancer
  • 相关文献

参考文献10

  • 1Hohenberger P,Gretschel S.Gastric cancer[J].Lancet,2003,362 (9380):305-315.
  • 2Thuss-Patience PC,Kretzschmar A,Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxcel and 5-Fu continuous infusion[J].Onkologic,2003,26 (1):63-65.
  • 3冯继锋,陆建伟,孙小峰.氟尿嘧啶/亚叶酸钙+紫杉醇联合化疗双周方案治疗晚期胃癌[J].癌症,2004,23(12):1704-1706. 被引量:14
  • 4Ridwelski K,Gebauer T,Fahlke J,et al.Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer[J].Ann Oncol,2001,12 (1):47-51.
  • 5Ajani JA,Baker J,Pisters PW,et al.Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma[J].Oncology Williston Park,2001,15(Suppl 5):52-54.
  • 6Louvet C,Andre T,Tigaud JM,et al.Phase study of oxaliplatin,fluorouracil,and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2002,20(23):4543-4548.
  • 7陈强,金懋林,沈琳,张晓东,吴晴,王清水,陈黎,李楠,袁耀宗,王永华,刘端祺,安晓华.表柔比星、亚叶酸钙、氟尿嘧啶与顺铂联合化疗方案(ECF-L)治疗晚期胃癌的疗效与安全性临床研究[J].中国癌症杂志,2003,13(2):102-105. 被引量:18
  • 8Adjci AA,Argiris A,Murren JR.Docetaxel and irinotecan,alone and in combination,in the treatment of non-small cell lung cancer[J].Semin Oncol,1999,26 (Suppl 16):32-40.
  • 9Ajani JA.Docetaxel in combination for advanced gastric cancer.Gastric Cancer,2002,5(Suppl 1):31-34.
  • 10Roth AD,Maibach R,Martinelli G,et al.Docetaxel(Taxotere) Cisplatin(TC):an effective drug combination in gastric carcinoma.Swiss Group for Clinical Cancer Research(SAKK),and the European Institute of Oncology(EIO)[J].Ann Oncol,2000,11 (3):301-306.

二级参考文献17

  • 1Schipper DL, Wagener DJT. Chemotherapy of gastric cancer[ J ]. Auticancer Drugs, 1996,7 (2) : 137-149.
  • 2Seymour MT, Dent JT, Papamiehael D, et al. Epirubicin,cisplatin and oral UFT with leueovorin ( ' ECU' ) : A phase I-II study in patients with advanced upper gastrointestinal tract cancer [ J ]. Ann Oncolo, 1999,10 ( 11 ) : 1329-1333.
  • 3Kim YH, Kim BS, Seo JH, et al. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma [ J ].Oncology (Huntingt) , 1999, 13(7 Suppl 3 ) :64-68.
  • 4Macdonald JS, Schein P, Woolley P, et al. 5 '-fluorouracil,doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer [ J ]. Ann Intl Med, 1980,93 ( 4 ) :533-536.
  • 5Wils J. The treatment of advanced gastric cancer [ J ]. Semin Oncolo, 1996,23(3) :397-406.
  • 6Clark JL, Kucuk O, Benson A, et al. Phase Ⅱ trial of etoposide,doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group Study[J] .Am J Clin Oncology ,1995,18(4) :318-324.
  • 7Cervantes A, Villar-Grimalt A, Abad A, et al. 5-Fluorouracil,folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase Ⅱ trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) [ J]. Ann Oncology, 1993,4(9 ) :753-757.
  • 8Bamias A, Hill ME, Cunningham D, et al. Epirubiein,eisplatin, and protracted venous infusion of 5'-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life and survival[ J]. Cancer, 1996,77(10) : 1978-1985.
  • 9Findlay M, Cunningham D, Norman A, et al. A phase Ⅱ study in advanced gastroesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5'-fluorouracil(ECF) [J] .Ann Oncology,1994,5(7) :609-616.
  • 10Ohtsu A,Boku N,Tamura K,et al. An early phaseⅡ study of a 3-hour infusion of paclitaxel for advanced gastric cancer [J]. Am J Clin Oncol,1998,21(4):416- 419.

共引文献28

同被引文献40

  • 1冯继锋,陆建伟,孙小峰.氟尿嘧啶/亚叶酸钙+紫杉醇联合化疗双周方案治疗晚期胃癌[J].癌症,2004,23(12):1704-1706. 被引量:14
  • 2杨锡贵,贾丽雅,刘志芳,步兵,齐洁林,张锡芹,周登峰,王明玉,刘蒲香.TCLF方案治疗晚期胃癌21例[J].临床肿瘤学杂志,2006,11(8):629-631. 被引量:7
  • 3秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 4胡国勇,胡娟,杨建国,丁岩冰,吴健,肖炜明.卡培他滨联合草酸铂和紫杉醇一线治疗晚期或转移性胃癌[J].咸宁学院学报(医学版),2006,20(6):487-489. 被引量:4
  • 5Sulkes A, Smyth J, Sessa C, et al. Docetaxel (Taxotere) in advanced gastric cancer: results of a phase Ⅱ clinical trial. EORTC Early Clinical Trials Group [J]. Br J Cancer, 1994, 70(2): 380-383.
  • 6Einzig AI, Neuberg D, Remick SC, et al. Phase Ⅱ trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol EI293[J]. Med Oncol, 1996, 13(2): 87-93.
  • 7Mavroudis D, Kourousis C, Androulakis N, et al. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase Ⅱ trial[J]. Am J Clin Oncol, 2000, 23(4): 341-344.
  • 8Bang YJ, Kang WK, Kang YK, et al. Docetaxel 75mg/m^2 is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase Ⅱ trial[J]. Jpn J Clin Oncol, 2002, 32(7): 248-254.
  • 9Ajani JA, Fodor M, Van Cutsem E, et al. Multinational randomized phase Ⅱ trial of docetaxel (T) and cisplatin (C) with or without 5-fluorouracil (FU) in patients (pts) with advanced gastric or GE junction adenocarcinoma (AGC-AGEJC)[J]. Proc Am Soc Clin Oncol, 2000,19: 247a
  • 10Barone C, Basso M, Schinzari G, et al. Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer[J]. Gastric Cancer, 2007, 10 (2):104-111.

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部